The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
Abstract
Volunteers experimentally infected with influenza A/Texas/36/91 (H1N1) virus and treated with the neuraminidase (NA) inhibitor oseltamivir were monitored for the emergence of drug-resistant variants. Two (4%) of 54 resistant viruses were detected by NA inhibition assay among last-day isolates recovered from 54 drug recipients. They bore a substitution His274Tyr in the NA. Hemagglutinin (HA) variants detected in the placebo group differed from the egg-adapted inoculum virus by virtue of amino acid substitutions at residues 137, 225, or both. These variants had a higher affinity for Neu5Ac(alpha2-6)Gal-containing receptors, which are characteristic of human respiratory epithelium, than for Neu5Ac(alpha2-3)Gal-containing receptors, which are typical of chicken egg allantoic membrane. Although appearing to be more sensitive to oseltamivir in humans, the variants with increased affinity for Neu5Ac(alpha2-6)Gal receptors were less sensitive than the Neu5Ac(alpha2-3)Gal-binding variants in Madin-Darby canine kidney cells. Thus, HA affinity for receptors is an essential feature of influenza virus susceptibility to NA inhibitors, both in cell culture and in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potier, M., Mameli, L., Bélisle, M., Dallaire, L., & Melançon, S. B. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90362-2 · Cited by 815
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 789
Receptor Specificity in Human, Avian, and Equine H2 and H3 Influenza Virus Isolates
Connor, R. J., Kawaoka, Y., Webster, R. G., & Paulson, J. C. (1994) · Virology · doi:10.1006/viro.1994.1615 · Cited by 782
Influenza virus neuraminidase inhibitors
Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11433-8 · Cited by 730
Self-citationHayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550
Self-citationNobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y., & Nakajima, K. (1991) · Virology · doi:10.1016/0042-6822(91)90588-3 · Cited by 471
Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus
Gubareva, L. V., Matrosovich, M. N., Brenner, M. K., Bethell, R. C., & Webster, R. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/314440 · Cited by 432
Self-citationWoods, J. M., Bethell, R. C., Coates, J. A., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, D. M., Ticehurst, J., Tilling, J., & Walcott, S. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1473 · Cited by 312
Plaque inhibition assay for drug susceptibility testing of influenza viruses
Hayden, F. G., Cote, K. M., & Douglas, R. G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.5.865 · Cited by 278
Self-citationIto, T., Suzuki, Y., Mitnaul, L., Vines, A., Kida, H., & Kawaoka, Y. (1997) · Virology · doi:10.1006/viro.1996.8323 · Cited by 264
Gambaryan, A. S., Tuzikov, A. B., Piskarev, V. E., Yamnikova, S. S., Lvov, D. K., Robertson, J. S., Bovin, N. V., & Matrosovich, M. N. (1997) · Virology · doi:10.1006/viro.1997.8572 · Cited by 261
Self-citationWagner, R., Wolff, T., Herwig, A., Pleschka, S., & Klenk, H.-D. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6316-6323.2000 · Cited by 249
Ito, T., Suzuki, Y., Takada, A., Kawamoto, A., Otsuki, K., Masuda, H., Yamada, M., Suzuki, T., Kida, H., & Kawaoka, Y. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3357-3362.1997 · Cited by 218
Richman, D. D. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.004 · Cited by 216
Gubareva, L. V., Robinson, M. J., Bethell, R. C., & Webster, R. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3385-3390.1997 · Cited by 212
Self-citationGubareva, L. V., Bethell, R., Hart, G. J., Murti, K. G., Penn, C. R., & Webster, R. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1818-1827.1996 · Cited by 202
Self-citationBaum, L. G., & Jc, P. (1990) · PubMed · Cited by 198
Effects of Egg-Adaptation on the Receptor-Binding Properties of Human Influenza A and B Viruses
Gambaryan, A. S., Robertson, J. S., & Matrosovich, M. N. (1999) · Virology · doi:10.1006/viro.1999.9732 · Cited by 197
Self-citationMcKimm‐Breschkin, J. L., Blick, T., Sahasrabudhe, A., Tiong, T. S., Marshall, D., Hart, G. J., Bethell, R. C., & Penn, C. R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.40 · Cited by 151
Tai, C. Y., Escarpe, P. A., Sidwell, R. W., Williams, M. A., Lew, W., Wu, H., Kim, C. U., & Mendel, D. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3234 · Cited by 147
Blick, T., Sahasrabudhe, A., McDonald, M., Owens, I. J., Morley, P. J., Fenton, R. J., & McKimm‐Breschkin, J. L. (1998) · Virology · doi:10.1006/viro.1998.9194 · Cited by 108
Rocha, E. P., Xu, X., Hall, H. E., Allen, J., Regnery, H. L., & Cox, N. J. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-11-2513 · Cited by 99
MUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTION
Burnet, F. M. (1948) · Immunology and Cell Biology · doi:10.1038/icb.1948.38 · Cited by 93
Clinical influenza virus and the embryonated Hen's egg
Robertson, J. S. (1993) · Reviews in Medical Virology · doi:10.1002/rmv.1980030206 · Cited by 89
Barnett, J. M., Cadman, A., Burrell, F., Madar, S., Lewis, A., Tisdale, M., & Bethell, R. C. (1999) · Virology · doi:10.1006/viro.1999.0058 · Cited by 72
Bantia, S., Ghate, A. A., Ananth, S. L., Babu, Y. S., Air, G. M., & Walsh, G. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.801 · Cited by 50
The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccinees
Abbasi, S., Gruber, W. C., Edwards, K. M., Gubareva, L. V., Webster, R. G., & Kawaoka, Y. (1995) · Virus Research · doi:10.1016/0168-1702(95)00097-6 · Cited by 3
Self-citation
Cited by
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
Oseltamivir Resistance during Treatment of Influenza A (H5N1) Infection
de Jong, M. D., Thanh, T. T., Khanh, T. H., Hien, V. M., Smith, G. J. D., Chau, N. V., Cam, B. V., Qui, P. T., Ha, D. Q., Guan, Y., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa054512 · Cited by 901
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Russell, R. J., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., & Skehel, J. J. (2006) · Nature · doi:10.1038/nature05114 · Cited by 813
Resistant influenza A viruses in children treated with oseltamivir: descriptive study
Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 786
Self-citation
Metadata
- Authors
- Gubareva, L. V., Kaiser, L., Matrosovich, M. N., Soo‐Hoo, Y., & Hayden, F. G.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-15
- Volume
- 183
- Issue
- 4
- Pages
- 523-531
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2129728733
- Cited by
- 318
- References
- 27
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.